Release Date: 08/10/13 15:19 Summary: Quarterly Cashflow Report Price Sensitive: Yes Download Document 129.7KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%